SAN DIEGO (AP) — SAN DIEGO (AP) — ImmunityBio, Inc. (IBRX) on Monday reported a loss of $184.6 million in its third quarter. On a per-share basis, the San Diego-based company said it had a loss of 18 cents. Losses, adjusted for non-recurring costs, came to 10 cents per share. The immunotherapy company posted revenue...